Resolution No:109-5-13
Title:Definition of Pharmacy Compounding
Action: PASS

WHEREAS, pharmacy compounding is regulated by the state boards of pharmacy as a part of the practice of pharmacy; and

WHEREAS, pharmaceutical manufacturing is regulated by the United States Food and Drug Administration (FDA); and

WHEREAS, a regulatory void in the definitions of and the distinctions between pharmacy compounding and pharmaceutical manufacturing exists that has allowed manufacturing to occur under the guise of pharmacy compounding with tragic consequences;

THEREFORE BE IT RESOLVED that the National Association of Boards of Pharmacy (NABP) and the state boards of pharmacy work with FDA and other interested parties to establish mutually agreeable definitions for pharmacy compounding and pharmaceutical manufacturing; and

BE IT FURTHER RESOLVED that NABP revise the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy to reflect the new definitions.

(Resolution passed at the NABP 109th Annual Meeting in St Louis, MO)